Abatacept

Abatacept is a medication used to treat autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. It is a T-cell costimulation modulator, which works by blocking certain receptors on the surface of T cells that are involved in the progression of the autoimmune response. Abatacept can help to reduce inflammation and joint damage, as well as improve physical function. It is given as an intravenous infusion and is typically used in combination with other medications.

Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases, primarily rheumatoid arthritis, by regulating the activity of the immune system. Here's a breakdown of its key points:

Type of drug:

  • Biological therapy: Abatacept targets the underlying cause of inflammation by specifically modifying the immune system's response.

Conditions treated:

  • Moderate to severe rheumatoid arthritis: Abatacept is usually prescribed when other disease-modifying antirheumatic drugs (DMARDs) haven't been effective or are not tolerated by the patient.
  • Polyarticular juvenile idiopathic arthritis (pJIA): This is a type of severe arthritis affecting multiple joints in children aged 2 years and above.
  • Psoriatic arthritis: Abatacept can help manage the symptoms of active psoriatic arthritis in adults and children aged 2 years and above.

Mechanism of action:

  • Abatacept acts as a modified antibody, specifically targeting a molecule called cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) on T cells.
  • T cells are immune cells that play a crucial role in the body's defense system. However, in autoimmune diseases like rheumatoid arthritis, overactive T cells mistakenly attack healthy tissues, leading to inflammation and joint damage.
  • By binding to CTLA-4, Abatacept prevents T cells from becoming fully activated, thereby dampening the immune response and reducing inflammation in the joints.

Important to note:

  • Abatacept does not cure autoimmune diseases but can significantly improve symptoms, slow disease progression, and potentially prevent further joint damage.
  • It is administered via intravenous infusion by a healthcare professional, typically once a month.
  • Like any medication, Abatacept can cause side effects, though some are more common than others. It's crucial to discuss these potential risks and benefits with your doctor before starting treatment.

Remember, this information is intended for general knowledge purposes only and should not be a substitute for professional medical advice. Always consult with a qualified healthcare professional for diagnosis, treatment, and personalized recommendations.

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AA Selective immunosuppressants
External Links